Moving from assessments to implementation: promising practices for strengthening multisectoral antimicrobial resistance containment capacity

[1]  J. Rodríguez-Baño,et al.  Healthcare-associated infections in Africa: a systematic review and meta-analysis of point prevalence studies , 2022, Journal of pharmaceutical policy and practice.

[2]  T. Apalata,et al.  Prevalence of Escherichia coli Producing Extended Spectrum Beta-Lactamase (ESBL) Driven Septicaemia in Children Aged 0–2 Years in Two Districts Hospitals in Yaounde, Cameroon , 2022, Bacteria.

[3]  O. Soge,et al.  Antimicrobial resistance including Extended Spectrum Beta Lactamases (ESBL) among E. coli isolated from kenyan children at hospital discharge , 2022, PLoS neglected tropical diseases.

[4]  A. Stergachis,et al.  Point Prevalence Survey of Antibiotic Use across 13 Hospitals in Uganda , 2022, Antibiotics.

[5]  Alan D. Lopez,et al.  Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis , 2022, The Lancet.

[6]  B. Mmbaga,et al.  Prevalence and patient related factors associated with Extended-Spectrum Beta-Lactamase producing Escherichia coli and Klebsiella pneumoniae carriage and infection among pediatric patients in Tanzania , 2021, Scientific Reports.

[7]  Mekdes Alemu Tola,et al.  High prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae fecal carriage among children under five years in Addis Ababa, Ethiopia , 2021, PloS one.

[8]  R. Gómez Huelgas,et al.  Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID , 2021, PloS one.

[9]  M. Asaduzzaman,et al.  Human Colonization with Extended-Spectrum Beta-Lactamase-Producing E. coli in Relation to Animal and Environmental Exposures in Bangladesh: An Observational One Health Study , 2021, Environmental health perspectives.

[10]  Tamara Hafner,et al.  Strengthening multisectoral coordination on antimicrobial resistance: a landscape analysis of efforts in 11 countries , 2021, Journal of pharmaceutical policy and practice.

[11]  G. Kang,et al.  Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: A World Health Organization Action Framework , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  A. Stergachis,et al.  Antimicrobial use across six referral hospitals in Tanzania: a point prevalence survey , 2020, BMJ Open.

[13]  A. Stergachis,et al.  National Consumption of Antimicrobials in Tanzania: 2017–2019 , 2020, Frontiers in Pharmacology.

[14]  G. Ippolito,et al.  Antimicrobial resistance preparedness in sub-Saharan African countries , 2020, Antimicrobial resistance and infection control.

[15]  N. Ahmed,et al.  Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Drinking Water Samples From a Forcibly Displaced, Densely Populated Community Setting in Bangladesh , 2020, Frontiers in Public Health.

[16]  R. Hendriksen,et al.  Extended-spectrum ß-lactamase-producing Escherichia coli among humans, chickens and poultry environments in Abuja, Nigeria , 2020, One Health Outlook.

[17]  U. Baker,et al.  How and under what circumstances do quality improvement collaboratives lead to better outcomes? A systematic review , 2020, Implementation Science.

[18]  Brian Thompson,et al.  The Threat of Antibiotic Resistance in Changing Climate , 2020, Microorganisms.

[19]  E. D. de Villiers,et al.  Whole genome sequences of multi-drug resistant Escherichia coli isolated in a Pastoralist Community of Western Uganda: Phylogenomic changes, virulence and resistant genes , 2020, bioRxiv.

[20]  N. Kandel,et al.  Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries , 2020, The Lancet.

[21]  H. Leslie,et al.  Antibiotic exposure among children younger than 5 years in low-income and middle-income countries: a cross-sectional study of nationally representative facility-based and household-based surveys. , 2019, The Lancet. Infectious diseases.

[22]  Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries: a WHO practical toolkit , 2019, JAC-antimicrobial resistance.

[23]  A. Rashford,et al.  Joint external evaluation of the International Health Regulation (2005) capacities: current status and lessons learnt in the WHO African region , 2019, BMJ Global Health.

[24]  B. Adhikari,et al.  Tackling antimicrobial resistance in low-income and middle-income countries , 2019, BMJ Global Health.

[25]  F. Berthe,et al.  Pulling Together to Beat Superbugs Knowledge and Implementation Gaps in Addressing Antimicrobial Resistance , 2019 .

[26]  A. Sundsfjord,et al.  High prevalence of multidrug resistant ESBL- and plasmid mediated AmpC-producing clinical isolates of Escherichia coli at Maputo Central Hospital, Mozambique , 2019, BMC Infectious Diseases.

[27]  J. Hughes,et al.  Critical Importance of a One Health Approach to Antimicrobial Resistance , 2019, EcoHealth.

[28]  P. Collignon,et al.  Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis. , 2018, The Lancet. Planetary health.

[29]  A. Jha,et al.  Analysis of results from the Joint External Evaluation: examining its strength and assessing for trends among participating countries , 2018, Journal of global health.

[30]  H. Goossens,et al.  Global increase and geographic convergence in antibiotic consumption between 2000 and 2015 , 2018, Proceedings of the National Academy of Sciences.

[31]  C. Chintu,et al.  Multidisciplinary and multisectoral coalitions as catalysts for action against antimicrobial resistance: Implementation experiences at national and regional levels , 2018, Global public health.

[32]  E. Ashley,et al.  Antimicrobial resistance in Africa: a systematic review , 2017, BMC Infectious Diseases.

[33]  G. Rodier,et al.  Joint external evaluation process: bringing multiple sectors together for global health security. , 2017, The Lancet. Global health.

[34]  Z. Memish,et al.  The 17th International Congress on Infectious Diseases workshop on developing infection prevention and control resources for low- and middle-income countries , 2017, International Journal of Infectious Diseases.

[35]  Kaustubh G Joshi,et al.  Resistance , 2017, British Medical Journal.

[36]  S. Godreuil,et al.  High prevalence of extended-spectrum ß-lactamase producing enterobacteriaceae among clinical isolates in Burkina Faso , 2016, BMC Infectious Diseases.

[37]  D. Akena,et al.  Household antimicrobial self-medication: a systematic review and meta-analysis of the burden, risk factors and outcomes in developing countries , 2015, BMC Public Health.

[38]  Jing Zhang,et al.  WHO: draft global action plan on antimicrobial resistance , 2015 .

[39]  J. Klimeš,et al.  Low Rates of Antimicrobial-Resistant Enterobacteriaceae in Wildlife in Taï National Park, Côte d’Ivoire, Surrounded by Villages with High Prevalence of Multiresistant ESBL-Producing Escherichia coli in People and Domestic Animals , 2014, PloS one.

[40]  F. van Leth,et al.  Antimicrobial drug resistance among clinically relevant bacterial isolates in sub-Saharan Africa: a systematic review. , 2014, The Journal of antimicrobial chemotherapy.

[41]  J. Gala,et al.  Antimicrobial resistance in urinary isolates from inpatients and outpatients at a tertiary care hospital in South-Kivu Province (Democratic Republic of Congo) , 2014, BMC Research Notes.

[42]  O. Doumbo,et al.  Surveillance for Antimicrobial Drug Resistance in Under-Resourced Countries , 2014, Emerging infectious diseases.

[43]  I. Okeke,et al.  Non-prescription antimicrobial use worldwide: a systematic review. , 2011, The Lancet. Infectious diseases.

[44]  English Only.  THE PEOPLE'S REPUBLIC OF BANGLADESH , 2006 .

[45]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..